Ministry Of Health: Herd Immunity Is Still A Government Target

Screenshot of the Spokesperson for the COVID-19 Vaccination of the Indonesian Ministry of Health, Siti Nadia Tarmizi (Photo: Andi Firdaus/Antara)

JAKARAT - Spokesperson for the COVID-19 Vaccination of the Indonesian Ministry of Health Siti Nadia Tarmizi said herd immunity of 70 percent of the population in Indonesia through vaccination is still the government's target to get out of the pandemic. can be achieved, as long as people get the first dose and the second dose sooner," said Siti Nadia Tarmizi when attending a virtual discussion event organized by LKBN ANTARA and monitored from Jakarta, Tuesday. Nadia said the efficacy of the COVID-19 vaccine that is now available in Indonesia is still relevant to the current development of the Corona virus mutation. He said that since the beginning of the vaccine procurement, the government has measured the lowest efficacy limit ranging from 55 to 60 percent to protect the public from transmission of SARS-CoV-2 that causes COVID-19. "So if we look at our initial calculation was that the vaccine efficacy was 55 to 60 percent. We have already taken the lower limit of the efficacy of a vaccine," he said.

According to Nadia, the vaccine efficacy is currently being injected to 70 percent of the population in Indonesia based on the age group of 12 years and over. percent of the population," he said. Nadia added that as many as seven types of vaccines currently available in Indonesia, namely Pfizer, Moderna, Sinovac, Sinopharm, AstraZeneca, Bio Farma and Novavax vaccines are still in accordance with the directives of the World Health Organization (WHO) as effective vaccines to prevent transmission. "We have confirmed that these seven types of vaccines are vaccines that have already completed phase three clinical trials, even globally they have also been recognized by WHO, then they have obtained emergency use permits. This means that the quality of safety has been recognized globally. ," he said.